Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein

Journal of Immunology

Volumn 164, Issue 7, 2000, Pages 3924-3931

  Matejuk, Agata ^a,b,c   Vandenbark, Arthur A ^a,c   Burrows, Gregory G ^a,c   Bebo Jr , Bruce F ^a,c   Offner, Halina ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BV8S2 PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENE PRODUCT; HYBRID PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN BASIC PROTEIN; RANTES; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; MACROPHAGE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINATION;

EID: 0034176818     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.7.3924     Document Type: Article

References (39)

1. Oppenheim, J. J., C. O. C. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617.
2. Baggiolini, M., and C. A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunol. Today 15:127.
3. Alam, R., D. Kumar, D. Anderson-Walters, and P. A. Forsythe. 1994. Macrophage inflammatory protein-1α and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J. Immunol. 152:1298.
4. Rollins, B. J. 1997. Chemokines. Blood 90:909.
5. Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
6. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55:97.
7. Taub, D. D., and J. J. Oppenheim. 1994. Chemokines, inflammation, and immunity. Ther. Immunol. 1:229.
8. Gunn, M. D., V. N. Ngo, K. M. Ansel, E. H. Ekland, J. G. Cyster, and L. T. Williams. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799.
9. Legler, D. F., M. Loetscher, R. S. Roos, L. I. Clark, M. Baggiolini, and B. Moser. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187:655.
10. Yoshida, T., T. Imai, M. Kakizaki, M. Nishimura, S. Takagi, and O. Yoshie. 1998: Identification of single C motif-1/lymphotactin receptor XCR1. J. Biol. Chem. 273:16551.
11. Offner, H., K. Adlard, B. F. Beho, Jr., J. Schuster, G. G. Burrows, A. C. Buenafe, and A. A. Vandenbark. 1998. Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice. J. Immunol. 161:2178.
12. Hulkower K., C. F. Brosnan, D. A. Aquino, W. Cammer, S. Kulshrestha, M. P. Guida, D. A. Rapoport, and J. W. Berman. 1993. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150:2525.
13. Ransohoff, R. M., T. A. Hamilton, M. Tani, M. H. Stoler, H. E. Shick, J. A. Major, M. L. Estes, D. M. Thomas, and V. K. Tuohy. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:592.
14. Karpus, W. J., N. W. Lukacs, B. L. McRae, R. M. Strieter, S. L. Kunkel, and S. D. Miller. 1995. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:5003.
15. Godiska, R., D. Chantry, G. N. Dietsch, and P. W. Gray. 1995. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:167.
16. Miyagishi, R., S. Kikuchi, C. Takayama, Y. Inoue, and K. Tashiro. 1997. Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J. Neuroimmunol. 77:17.
17. Glabinski, A. R., M. Tani, R. M. Strieter, V. K. Tuohy, and R. M. Ransohoff. 1997. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:617.
18. Karpus, W. J., and K. J. Kennedy. 1997. MIP-1α and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukocyte Biol. 62:681.
19. Kennedy, K. J., R. M. Strieter, S. L. Kunkel, N. W. Lukacs, and W. J. Karpus. 1998. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1. J. Neuroimmunol. 92:98.
20. Jiang, Y., M. N. Salafranca, S. Adhikari, Y. Xia, L. Feng, M. K. Sonntag, C. M. deFiebre, N. A. Pennell, W. J. Streit, and J. K. Harrison. 1998. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J. Neuroimmunol. 86:1.
21. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, et al. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:807.
22. Balashov, K. E., J. B. Rottman, H. L. Weiner, and W. W. Hancock. 1999. CCR5 (+) and CXCR3 (+) T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 96:6873.
23. Goverman, J., A. Woods, L. Larson, L. P. Weiner, L. Hood, and D. M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72:551.
24. Vainiene, M., G. G. Burrows, K. Ariail, I. Robey, A. A. Vandenbark, and H. Offner. 1996. Neonatal injection of Lewis rats with recombinant Vβ8.2 induces T cell but not B cell tolerance and increased severity of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:475.
25. Kumar, V., and E. E. Sercarz. 1993. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909.
26. Bourdette, D. N., M. Vainiene, W. Morrison, R. Jones, M. J. Turner, G. A. Hashim, A. A. Vandenbark, and H. Offner. 1991. Myelin basic protein specific T cell lines and clones derived from the CNS of rats with EAE only recognize encephalitogenic epitopes. J. Neurosci. Res. 30:308.
27. Springer, T. A., 1994. Traffic signals for lymphocytes recirculation and leukocyte emigration: the multi-step paradigm. Cell 76:301.
28. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272:60.
29. Taub, D. D., J. R. Ortaldo, S. M. Turcovski-Corrales, M. L. Key, D. L. Longo, and W. J. Murphy 1996. β Chemokines costimulate lymphocyte cytolysis, proliferation and lymphokine production. J. Leukocyte Biol. 59:81.
30. Sallusto, F., A. Lanzavecchia, and C. R. Mackay. 1998. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 19:568.
31. Offner, H., R. Jacobs, B. F. Bebo, Jr., and A. A. Vandenbark. 1999. Treatments targeting the TCR: effects of TCR peptide-specific T cells on activation, migration, and encephalitogenicity of MBP-specifie T cells. Springer Semin. Immunopathol. 21:77.
32. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.
33. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, and A. Mantovani. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells and Th2s. J. Exp. Med. 187:129.
34. Schall, T. J., K. Bacon, K. J. Toy, and D. V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669.
35. Carr, M. W., S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91:3652.
36. Taub, D. D., A. R. Lloyd, K. Conlon, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809.
37. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61:246.
38. Hvas, J., C. McLean, J. Justesen, G. Kannourakis, L. Steinman, J. R. Oksenberg, and C. C. A. Bernard. 1997. Perivascular T cells express the pro-inflammatory chemokine RANTES in multiple sclerosis lesions. Scand. J. Immunol. 46:195.
39. Zou, L.-P., S.-H. Pelidou, N. Abbas, G. Deretzi, E. Mix, M. Schaltzbeerg, B. Winblad, and J. Zhu. 1999. Dynamics of production of MIP-1α, MCP-1 and MCP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J. Neuroimmunol. 98:168.